Interest in an Ebola vaccine among a U.S. national sample during the height of the 2014–2016 Ebola outbreak in West Africa

Julia E. Painter, Ralph DiClemente, Michael E. von Fricken

Research output: Contribution to journalArticle

Abstract

To better understand the association between Ebola-related attitudes and interest in receiving an Ebola virus vaccine, a survey was administered to a U.S. national sample using GfK's KnowledgePanel®. Among participants (N = 1417), 34.1% expressed interest in an Ebola vaccine for themselves. In the subset of participants with children aged 0–17 (N = 410), 38.1% expressed interest in an Ebola vaccine for their child. In multivariable analyses, vaccine interest for oneself was associated with perceived susceptibility to Ebola (p = 0.009), beliefs that the U.S. government should spend money to control Ebola (p = 0.002), and beliefs Ebola posed a national threat (p = 0.007). Vaccine interest for one's child was associated with perceived severity of Ebola (p = 0.018) and beliefs that the U.S. government should spend money to control Ebola (p = 0.003). Findings highlight the influence of personal and national threat beliefs on vaccine interest. Understanding the impact of threat beliefs may benefit vaccine campaign development during future pandemic threats.

Original languageEnglish (US)
Pages (from-to)508-512
Number of pages5
JournalVaccine
Volume35
Issue number4
DOIs
StatePublished - Jan 23 2017

Fingerprint

Ebola Vaccines
Western Africa
Disease Outbreaks
vaccines
Vaccines
sampling
Ebolavirus
Pandemics
vaccine development
pandemic

Keywords

  • Acceptability
  • Attitudes
  • Ebola
  • Interest
  • Vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Interest in an Ebola vaccine among a U.S. national sample during the height of the 2014–2016 Ebola outbreak in West Africa. / Painter, Julia E.; DiClemente, Ralph; von Fricken, Michael E.

In: Vaccine, Vol. 35, No. 4, 23.01.2017, p. 508-512.

Research output: Contribution to journalArticle

@article{f2a44cf0c6424420aec4fd45b2e644a6,
title = "Interest in an Ebola vaccine among a U.S. national sample during the height of the 2014–2016 Ebola outbreak in West Africa",
abstract = "To better understand the association between Ebola-related attitudes and interest in receiving an Ebola virus vaccine, a survey was administered to a U.S. national sample using GfK's KnowledgePanel{\circledR}. Among participants (N = 1417), 34.1{\%} expressed interest in an Ebola vaccine for themselves. In the subset of participants with children aged 0–17 (N = 410), 38.1{\%} expressed interest in an Ebola vaccine for their child. In multivariable analyses, vaccine interest for oneself was associated with perceived susceptibility to Ebola (p = 0.009), beliefs that the U.S. government should spend money to control Ebola (p = 0.002), and beliefs Ebola posed a national threat (p = 0.007). Vaccine interest for one's child was associated with perceived severity of Ebola (p = 0.018) and beliefs that the U.S. government should spend money to control Ebola (p = 0.003). Findings highlight the influence of personal and national threat beliefs on vaccine interest. Understanding the impact of threat beliefs may benefit vaccine campaign development during future pandemic threats.",
keywords = "Acceptability, Attitudes, Ebola, Interest, Vaccine",
author = "Painter, {Julia E.} and Ralph DiClemente and {von Fricken}, {Michael E.}",
year = "2017",
month = "1",
day = "23",
doi = "10.1016/j.vaccine.2016.11.093",
language = "English (US)",
volume = "35",
pages = "508--512",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Interest in an Ebola vaccine among a U.S. national sample during the height of the 2014–2016 Ebola outbreak in West Africa

AU - Painter, Julia E.

AU - DiClemente, Ralph

AU - von Fricken, Michael E.

PY - 2017/1/23

Y1 - 2017/1/23

N2 - To better understand the association between Ebola-related attitudes and interest in receiving an Ebola virus vaccine, a survey was administered to a U.S. national sample using GfK's KnowledgePanel®. Among participants (N = 1417), 34.1% expressed interest in an Ebola vaccine for themselves. In the subset of participants with children aged 0–17 (N = 410), 38.1% expressed interest in an Ebola vaccine for their child. In multivariable analyses, vaccine interest for oneself was associated with perceived susceptibility to Ebola (p = 0.009), beliefs that the U.S. government should spend money to control Ebola (p = 0.002), and beliefs Ebola posed a national threat (p = 0.007). Vaccine interest for one's child was associated with perceived severity of Ebola (p = 0.018) and beliefs that the U.S. government should spend money to control Ebola (p = 0.003). Findings highlight the influence of personal and national threat beliefs on vaccine interest. Understanding the impact of threat beliefs may benefit vaccine campaign development during future pandemic threats.

AB - To better understand the association between Ebola-related attitudes and interest in receiving an Ebola virus vaccine, a survey was administered to a U.S. national sample using GfK's KnowledgePanel®. Among participants (N = 1417), 34.1% expressed interest in an Ebola vaccine for themselves. In the subset of participants with children aged 0–17 (N = 410), 38.1% expressed interest in an Ebola vaccine for their child. In multivariable analyses, vaccine interest for oneself was associated with perceived susceptibility to Ebola (p = 0.009), beliefs that the U.S. government should spend money to control Ebola (p = 0.002), and beliefs Ebola posed a national threat (p = 0.007). Vaccine interest for one's child was associated with perceived severity of Ebola (p = 0.018) and beliefs that the U.S. government should spend money to control Ebola (p = 0.003). Findings highlight the influence of personal and national threat beliefs on vaccine interest. Understanding the impact of threat beliefs may benefit vaccine campaign development during future pandemic threats.

KW - Acceptability

KW - Attitudes

KW - Ebola

KW - Interest

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85009279435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009279435&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2016.11.093

DO - 10.1016/j.vaccine.2016.11.093

M3 - Article

C2 - 28040206

AN - SCOPUS:85009279435

VL - 35

SP - 508

EP - 512

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 4

ER -